Relay Therapeutics Inc (RLAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 09-2019 | 06-2019 | |
| Cash Flows From Operating Activities | |||
| Net Income | -75,305 | -51,392 | -31,719 |
| Depreciation Amortization | 350 | 132 | 636 |
| Accounts payable and accrued liabilities | N/A | 653 | 525 |
| Other Working Capital | 4,310 | 4,682 | 3,256 |
| Other Operating Activity | 4,512 | 2,553 | 1,433 |
| Operating Cash Flow | $-66,133 | $-43,372 | $-25,869 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | N/A | 117,000 | 18,000 |
| PPE Investments | -7,982 | -7,384 | -4,997 |
| Purchase Of Investment | N/A | -464,537 | -375,000 |
| Other Investing Activity | -311,042 | 0 | 0 |
| Investing Cash Flow | $-319,024 | $-354,921 | $-361,997 |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | N/A | 172 | 52 |
| Other Financing Activity | 5,606 | 5,661 | 5,665 |
| Financing Cash Flow | $5,606 | $5,833 | $5,717 |
| Beginning Cash Position | 422,383 | 422,383 | 422,383 |
| End Cash Position | 42,832 | 29,923 | 40,234 |
| Net Cash Flow | $-379,551 | $-392,460 | $-382,149 |
| Free Cash Flow | |||
| Operating Cash Flow | -66,133 | -43,372 | -25,869 |
| Capital Expenditure | N/A | -7,404 | -5,017 |
| Free Cash Flow | -66,133 | -50,776 | -30,886 |